Search for Clinical Trial Results
Glycogen Storage Disease - 119 Studies Found
Status | Study |
Completed |
Study Name: A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II Condition:
|
Completed |
Study Name: A Prospective, Observational Study in Patients With Late-Onset Pompe Disease Condition: Glycogen Storage Disease Type II Date: 2004-02-10 |
Completed |
Study Name: A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease Condition: Glycogen Storage Disease Type II Date: 2003-04-22 Interventions: Biological: Myozyme 20 mg/kg qow or 40mg/kg qow Othe |
Active, not recruiting |
Study Name: Sodium Valproate for GSDV Condition:
Date: 2015-08-11 Interventions: Drug: Sodium Valproate Subjects will receive sodium valproate modified release 20mg/kg/day (maximum dose |
Completed |
Study Name: Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602 Condition: Glycogen Storage Disease Type II Date: 2005-08-01 Interventions: Biological: Myozyme 20 mg/kg qow or 40 mg/kg qow Oth |
Recruiting |
Study Name: Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies Condition: Glycogen Storage Disease Type III Date: 2015-05-15 Interventions:
|
Recruiting |
Study Name: Respiratory Muscle Training in L-Onset Pompe Disease (LOPD) Condition: Glycogen Storage Disease Type II Date: 2016-06-13 Interventions:
|
Recruiting |
Study Name: Effect of Motor Development, Motor Function and Electrophysiologic Findings of IOPD Under ERT Condition: Glycogen Storage Disease Type II Date: 2016-04-26 Interventions: Other: observation study observation study |
Withdrawn |
Study Name: High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease Condition: Glycogen Storage Disease Type II Date: 2012-08-01 Interventions: Other: High Protein and Exercise Therapy along-with Nocturnal Enteral Feeding |